Protagen AG Sells Service Business

(PresseBox) - 07.2013 - Protagen AG, Dortmund, divested its 100% subsidiary Protagen Protein Services GmbH (PPS), to Zukunftsfond Heilbronn. The company was spun out in January 2012 and continued the business of the former operational division Protein Services, which accumulated unique expertise in the GMP-compliant protein analytics over the years.
"The sale of this profitable service business to a potent investor with complementary portfolio companies secures a sustainable growth for PPS, an internationally renowned specialist for protein characterization and biosimilar comparability. On the other hand, the capital injection generated by this transaction is a solid mid-term financing opportunity for the Protagen strategy in the area of novel diagnostics, i.e. Dx and CDx, and enables to start the development of own products for this growing market immediately. With this step, Protagen positions itself as highly attractive target for new VC investors", states Dr. Stefan Müllner, CEO.

PROTAGEN AG is a leading specialist in the development of novel diagnostic tests in autoimmune diseases. The company focuses its assay development programs on disease specific autoantibodies.
PROTAGEN expects to become the dominating provider for novel products in autoimmune-Dx and CDx.

Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: PresseBox
Datum: 02.07.2013 - 13:35 Uhr
Sprache: Deutsch
News-ID 275030
Anzahl Zeichen: 1447

contact information:
Town:

Dortmund

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 288 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Protagen AG Sells Service Business"
steht unter der journalistisch-redaktionellen Verantwortung von

Protagen AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Protagen Selected by Pfizer to Support Clinical Drug Development of a Novel Comp ...

Protagen announced today that a collaboration agreement with Pfizer Inc. has been signed. Under the collaboration, Protagen will use its proprietary SeroTag® process to attempt to discover prediction or patient stratification markers for a novel dr ...

Protagen counts on Kairos Expertise in Biobank- Management ...

Protagen AG, Dortmund, and Kairos GmbH, Bochum, a specialist in IT solutions for biobank management announced today a marketing & sales cooperation. Both companies are planning for a long term partnership in which Protagen will profit from the c ...

Protagen and NMI announce Co-Development of Multiplex Assays ...

Protagen AG, a specialist in in-vitro diagnostics and the Natural and Medical Sciences Institute at the University of Tübingen (NMI), have announced the signing of an agreement for joint development of multiplex assays for the diagnosis of autoimmu ...

Alle Meldungen von Protagen AG